ÓŵÂ88¹ÙÍøÍøÕ¾

Xianju
Xianju
CN
Xianju
Strive for the cause of health

Zhejiang Xianju Pharmaceutical Co. , Ltd. (Stock Code: 002332) formerly known as Xianju Pharmaceutical Factory, was founded in 1972, is the National Torch Program Key high-tech enterprises, the company¡¯s products Nothing in Common, adhere to the integration of raw materials, pharmaceutical business model, the main business is the development, production and sales of steroid raw materials and preparations. Xianju pharmaceutical advocates real culture, win-win culture and innovative culture, and adheres to the strategic concept of achieving win-win results in customers, enterprises, employees, society, etc. , it advocates the value idea that individual value is reflected in the process of realizing enterprise value and social value. Uphold the ¡°Integrity, hard work, openness, learning, responsibility, win-win¡±core values of the enterprise, the practice of ¡°Your health and happiness, my sincerity and service¡±business mission, we focus on the field of steroid with the development vision of ¡°Becoming the top ten supplier of steroid drugs in the world, becoming the enterprise welcomed by customers and employees¡±.


More XianjuXianju
3+2

manufacturing platforms + plants

17

wholly-owned and holding subsidiaries

3300

employees

980million yuan

Total capital stock

R&D and Innovation

heavily investing in the innovation, research, and development of new drugs, Xianju Pharmaceutical has established an international system of synchronous R&D operation, a R&D cooperation model and a technical platform for steroid BPC and preparations that feature multiple levels and key points.

Global Layout
Xianju has devised a preliminary technical framework with overseas high-end research institutes as the sources and Xianju Base as the implementer.
ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾
Europe ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾ ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾
Asia ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾ ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾
Africa ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾ ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾
Oceania ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾ ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾
Central and North America ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾ ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾
South America ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾ ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾
ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾
ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾Europe

Greece

Romania

Netherlands

Barrows

Italy

France

Belgium

Cyprus

Moldova

Spain

Russia

Turkey

Malta

ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾Asia

Uzbekistan

Lebanon

Vietnam

Jordan

Indonesia

India

Israel

Iraq

Syria

Singapore

Thailand

Sri Lanka

Saudi Arabia

Nepal

Myanmar

Bangladesh

Malaysia

Qatar

korea

Philippines

Pakistan

The United Arab Emirates

Japan

ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾Africa

Nigeria

South Africa

Kenya

Cote d'Ivoire

Ghana

Egypt

Algeria

ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾Oceania

New Zealand

Australia

ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾Central and North America

Dominican

Guatemala

Mexico

America

Canada

Honduras

Costa Rica

Panama

ÓŵÂ88¡¤(ÖйúÇø)¹Ù·½ÍøÕ¾South America

Chile

Uruguay

Peru

Brazil

Paraguay

Argentina

ÍøÕ¾µØÍ¼